About this trial
Intracranial atherosclerotic disease is an important cause of ischemic stroke, and intracranial stent implantation is increasingly used for patients with severe stenotic lesions. Evaluation of stent patency and detection of in-stent restenosis are essential during follow-up. Digital subtraction angiography (DSA) remains the reference standard for intracranial stent assessment; however, it is an invasive procedure associated with potential complications and radiation exposure. Conventional CT angiography may be limited by stent-related artifacts, including blooming artifact and beam-hardening effects, which can impair accurate evaluation of the stent lumen.
Eligibility criteria
Qualifiers
Age ≥18 years;
Patients with previously implanted intracranial arterial stents;
Undergoing follow-up CTA examination;
Available imaging data for analysis.
Disqualifiers
Severe motion artifacts;
Poor contrast enhancement;
Incomplete clinical or imaging data.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Xin Lou
Lead sponsor
Chinese PLA General Hospital
Sponsor institution